01 · Product Overview
Salmonellosis is one of the most significant challenges in commercial poultry production, causing both economic losses and food safety concerns. The GenzistNasr vaccine formulation, based on targeted antigens from the most prevalent Salmonella serovars, confers cellular and humoral immunity to protect flocks during critical production periods.
02 · Key Features
- Coverage of Salmonella Enteritidis and Typhimurium serovars
- Compatible with vaccination protocols for broiler and layer farms
- Reduces intestinal bacterial reservoir formation
- High stability in cold chain distribution
- Formulated with safe adjuvants
- Complete quality control documentation and research references
FIELD STUDY · 2025
In preliminary field studies, this vaccination protocol reduced Salmonella-related mortality by up to 70% in commercial flocks.
03 · Technical Specifications
Dosage Form
Injectable / Oral Suspension
Route
Subcutaneous, Intramuscular, or Drinking Water
Immunity Duration
Through the end of the production cycle
Storage
2–8°C
04 · Fields of Application
Broiler farms, layer flocks, breeder farms, slaughter and processing lines.
For further information, product datasheets, or technical consultation tailored to your process conditions, please contact the GenzistNasr team.